Hospital & Laboratory

The BIOFIRE TORCH System uses multiplex PCR technology to simultaneously test for a comprehensive grouping of targets in about an hour.

This alternative method to traditional stool testing is fast, sensitive, and comprehensive with a panel menu that includes bacteria, viruses, and parasites, causing infectious gastroenteritis.

The BIOFIRE GI Panel Mid is a midplex PCR test that will offer a more concise menu of 11 pathogen targets, complementing the legacy BIOFIRE® FILMARRAY® Gastrointestinal Panel .

The BIOFIRE^® Respiratory 2.1 (RP2.1) Panel use the syndromic approach to accurately detect and identify the pathogens most associated with respiratory infections. Fast and comprehensive results may enable better-informed diagnosis and treatment of patients.

The BIOFIRE ME Panel detects on 14 of the most common bacterial, viral, and yeast pathogens that cause central nervous system infections to help healthcare providers rapidly distinguish between bacterial and viral meningitis and optimize life-saving therapy. 

Using PCR technology, the BIOFIRE JI Panel is a syndromic test that delivers comprehensive results in one easy-to-read report.

Syndromic tests targeting a comprehensive menu of bacteria and viruses that cause pneumonia and other lower respiratory tract infections, as well as 7 genetic markers of antibiotic resistance.

The BIOFIRE BCID2 Panel tests for 43 targets associated with bloodstream infections, including Gram-negative bacteria, Gram-positive bacteria, yeast, and 10 antimicrobial resistance genes – all with one test and with results available in about an hour from positive blood culture.

The BIOFIRE 2.0 EZ Configuration facilitates rapid near-patient molecular diagnostic testing with results in about 45 minutes.

The BIOFIRE RP2.1-EZ Panel (EUA)* uses a syndromic approach to quickly identify SARS-CoV-2, along with 18 additional viral and bacterial pathogens with results in about 45 minutes.

Product not available outside of the U.S.

The choice of microbiologists worldwide for its ease-of-use and high-performance, the API® ID strip range is the global reference for identification. 10 API® strips are used every minute in the world.

BACT/ALERT^® culture media offers a comprehensive range of media bottles to ensure the recovery of a wide variety of microorganisms including bacteria, mycobacteria, and fungi – including our next generation Fastidious Antimicrobial Neutralization Plus media (FAN^® PLUS) offering optimized time to detection and recovery. 

The first fully automated blood culture system, helping to refine and redesign laboratory workflow to maximize efficiency, while providing the fastest clinically impactful results on the market.^1,2

The BIOFIRE^® FILMARRAY^® Tropical Fever (TF) Panel tests for a syndromic grouping of 6 bacteria, viruses and parasites most often associated with tropical fever infections. With just one test, results are available in ~50 minutes.

The BIOFIRE RP2.1 and RP2.1plus Panels use the syndromic approach to accurately detect and identify the pathogens most associated with respiratory infections. Fast and comprehensive results may enable better-informed diagnosis and treatment of patients.

Provides easy-to-use applications for clinical microbiologists: clinical pathogen outbreak management, microbiome profiling, and SARS-CoV-2 genomics variants identification.

Innovative and extensive range of chromogenic media for the simultaneous culture and identification of microorganisms in clinical specimens.

EMAG^® offers efficient and flexible extraction to manage both routine and challenging customer needs, supported by a committed and skilled team at bioMérieux.

ESTREAM^® offers high-precision automated PCR setup for streamlined workflow and secured results.

Clinicians often need more information than what primary AST can provide. Recognized around the world for their proven performance, ETEST^® ready to use reagent strips determine on-scale MICs.